GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress December 7, 2018 Press Release Banking, Finance & Real Estate, Press Releases, Science and Technology 0 Comments PRESS RELEASE Epidiolex® (cannabidiol) oral solution (CV), first FDA-approved plant-derived cannabinoid medicine launched in the U.S. - Conference call today at 4:30 p.m. EST - LONDON and CARLSBAD, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH,… Read More→
The Federal Government has acknowledged a patent on a cannabis based pharmaceutical as a legitimate and useful medicine June 29, 2018 Mark Goldfogel Op-Ed, Opinions 1 Comment G.W. Pharmaceuticals accomplished a feat that is about to change the course of history. They achieved drug approval for a plant-based medicine related to cannabis for treatment of certain conditions in children! This doesn’t apply only to states that have… Read More→
GW Pharmaceutical: A Cut Above the Rest September 28, 2016 Rob Meagher Company Stories, Science and Technology 0 Comments I think Forbes said it best in Debra Borchardt's recent article, "GW Pharmaceutical Gets Closer To Forcing FDA On Cannabis," with an  announcement a couple of weeks ago that its Clinical Phase 3 trial results for Epidolex were positive in paving… Read More→